These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20540789)

  • 1. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.
    Snoussi K; Mahfoudh W; Bouaouina N; Fekih M; Khairi H; Helal AN; Chouchane L
    BMC Cancer; 2010 Jun; 10():283. PubMed ID: 20540789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.
    Snoussi K; Mahfoudh W; Bouaouina N; Ahmed SB; Helal AN; Chouchane L
    Hum Immunol; 2006; 67(1-2):13-21. PubMed ID: 16698420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2 +1208 CT genotype may predict earlier clinical stage at diagnosis in patients with prostate cancer.
    Franz JM; Portela P; Salim PH; Berger M; Fernando Jobim L; Roesler R; Jobim M; Schwartsmann G
    Cytokine; 2017 Sep; 97():193-200. PubMed ID: 28668699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
    Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
    Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
    Kamali-Sarvestani E; Aliparasti MR; Atefi S
    Neoplasma; 2007; 54(6):484-9. PubMed ID: 17949231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children.
    Javor J; Bucova M; Cervenova O; Kralinsky K; Sadova E; Suchankova M; Liptakova A
    Int J Immunogenet; 2012 Aug; 39(4):338-45. PubMed ID: 22325052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma.
    Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Helal AN; Chouchane L
    BMC Cancer; 2006 Feb; 6():38. PubMed ID: 16504019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.
    Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L
    Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Preliminary Report of the Relationship Between Gene Polymorphism of
    Yao W; Sun Y; Sun Y; Chen P; Meng Z; Xiao M; Yang X
    DNA Cell Biol; 2019 Dec; 38(12):1512-1518. PubMed ID: 31613654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.
    Chakraborty A; Mishra AK; Soni A; Regina T; Mohil R; Bhatnagar D; Bhatnagar A; Chintamani C; Sharma PC; Saxena S
    Cancer Detect Prev; 2009; 32(5-6):386-94. PubMed ID: 19588543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM
    Cytokine; 2012 Nov; 60(2):473-7. PubMed ID: 22763041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
    Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
    Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
    Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
    Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
    Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
    Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease.
    Duymaz-Tozkir J; Yilmaz V; Uyar FA; Hajeer AH; Saruhan-Direskeneli G; Gül A
    J Rheumatol; 2005 Jan; 32(1):93-7. PubMed ID: 15630732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
    An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
    Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.